Aimmune Therapeutics, Inc.
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2011-01-01
- Employees
- 275
- Market Cap
- -
- Website
- http://www.aimmune.com
Clinical Trials
52
Trial Phases
4 Phases
Drug Approvals
2
Clinical Trials
Distribution across different clinical trial phases (52 trials with phase data)• Click on a phase to view related trials
Aimmune Longitudinal Collaboration Study
- Conditions
- Stool Spore Colony Forming UnitsMicrobiome CompositionDietary FiberStress
- First Posted Date
- 2025-10-20
- Last Posted Date
- 2025-10-20
- Lead Sponsor
- Aimmune Therapeutics, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT07218640
- Locations
- 🇺🇸
Aimmune Therapeutics Manufacturing, Ambler, Pennsylvania, United States
🇺🇸GoodNature Tempe, Ambler, Pennsylvania, United States
Oral Immunotherapy for Desensitization in Children, Adolescents, and Young Adults With Hen Egg Allergy
- Conditions
- Hen Egg Allergy
- First Posted Date
- 2019-08-14
- Last Posted Date
- 2022-03-10
- Lead Sponsor
- Aimmune Therapeutics, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT04056299
- Locations
- 🇺🇸
Arkansas Children's Hospital, Little Rock, Arkansas, United States
🇺🇸Peninsula Research Associates, Rolling Hills Estates, California, United States
🇺🇸Allergy & Asthma Medical Group and Research Center, A.P.C, San Diego, California, United States
Peanut Oral Immunotherapy Study of Early Intervention for Desensitization
- Conditions
- Peanut Allergy
- First Posted Date
- 2018-11-09
- Last Posted Date
- 2023-03-02
- Lead Sponsor
- Aimmune Therapeutics, Inc.
- Target Recruit Count
- 146
- Registration Number
- NCT03736447
- Locations
- 🇺🇸
Arkansas Children's Hospital, Little Rock, Arkansas, United States
🇺🇸Sean N. Parker Center for Allergy & Asthma Reseach, LPCH at El Camino Hospital, Mountain View, California, United States
🇺🇸Peninsula Research Associates, Inc., Rolling Hills Estates, California, United States
Real World, Open Label, QOL Assessment of Peanut Immunotherapy AR101 in Children and Adolescents
- Conditions
- Peanut Allergy
- First Posted Date
- 2018-10-12
- Last Posted Date
- 2021-07-13
- Lead Sponsor
- Aimmune Therapeutics, Inc.
- Target Recruit Count
- 1
- Registration Number
- NCT03703791
- Locations
- 🇪🇸
Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, Spain
🇪🇸Corporacio Sanitaria Parc Tauli, Sabadell, Barcelona, Spain
🇪🇸Hospital Universitario Severo Ochoa, Leganes, Madrid, Spain
AR101 Real-World Open-Label Extension Study
- Conditions
- Peanut Allergy
- First Posted Date
- 2017-11-09
- Last Posted Date
- 2021-11-02
- Lead Sponsor
- Aimmune Therapeutics, Inc.
- Target Recruit Count
- 243
- Registration Number
- NCT03337542
- Locations
- 🇺🇸
Clinical Research Center of Alabama, Birmingham, Alabama, United States
🇺🇸Medical Research of Arizona, Scottsdale, Arizona, United States
🇺🇸Banner University of Arizona Medical Center, Tucson, Arizona, United States
- Prev
- 1
- 2
- 3
- Next